Opioid Resource Center
Guidance for Practicing Primary Care
Thoughts on the CDC update on opioid prescribing guidelines
While the guidelines do a great job recommending how to prescribe opioids, they do not go into any depth discussing other treatment options.
From the Journals
Watch for buprenorphine ‘spiking’ in urine drug tests
Some patients undergoing treatment for opioid use disorder alter their urine drug test results by adding buprenorphine directly to their urine.
Latest News
Opioid overdose is an important cause of postpartum death
Ob.gyns. have an opportunity to screen patients to identify those at high risk for opioid use disorder or opioid overdose, and a new law eases...
News from the FDA/CDC
FDA moves to stop the spread of illicit ‘tranq’ in the U.S.
The agency “remains concerned about the increasing prevalence of xylazine mixed with illicit drugs,” said FDA Commissioner Robert M. Califf, MD....
Latest News
DEA proposals on telehealth for controlled substances draw fire
Both proposals would allow providers to prescribe a 30-day supply of a controlled substance or buprenorphine, but then require a face-to-face...
From the Journals
Buprenorphine proves effective for fentanyl users in the ED
A new study provides additional information about emergency department buprenorphine as fentanyl becomes increasingly prevalent.
From the Journals
Which nonopioid meds are best for easing acute low back pain?
Acute low back pain (LBP) remains a common cause of disability worldwide, with a high socioeconomic burden.
Feature
Physician pleads guilty to 52 counts in opioid scheme
The neuromuscular medicine specialist also admitted to ignoring patient requests to lower dosages and signs that patients were selling prescribed...
Commentary
The X-waiver is dead
When Erin Schanning lost her brother to an overdose, she wanted to know what could have been done to have helped him.
Latest News
Buprenorphine linked with lower risk for neonatal harms than methadone
The risk of adverse maternal outcomes was similar between the two treatments, according to a large study.
From the Journals
HCV reinfection uncommon among people who inject drugs
In a new study, most reinfections occurred within 24 weeks of completing treatment.